BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $1.44 Million Stake in DaVita Inc. (NYSE:DVA)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp cut its holdings in shares of DaVita Inc. (NYSE:DVA) by 14.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 8,787 shares of the company’s stock after selling 1,493 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in DaVita were worth $1,440,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. boosted its position in DaVita by 1.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock valued at $776,000 after purchasing an additional 70 shares during the last quarter. Wedmont Private Capital increased its holdings in shares of DaVita by 4.4% in the third quarter. Wedmont Private Capital now owns 1,776 shares of the company’s stock valued at $280,000 after purchasing an additional 75 shares during the last quarter. Blue Trust Inc. raised its holdings in DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after acquiring an additional 78 shares during the period. First Trust Direct Indexing L.P. increased its stake in shares of DaVita by 2.9% during the third quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company’s stock worth $500,000 after purchasing an additional 86 shares during the period. Finally, Nisa Investment Advisors LLC lifted its holdings in shares of DaVita by 0.3% during the third quarter. Nisa Investment Advisors LLC now owns 36,820 shares of the company’s stock worth $6,036,000 after buying an additional 126 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

Shares of NYSE DVA opened at $161.39 on Friday. The company has a market capitalization of $13.23 billion, a PE ratio of 17.41, a PEG ratio of 0.93 and a beta of 0.90. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The stock’s 50 day moving average price is $158.65 and its 200-day moving average price is $149.93. DaVita Inc. has a twelve month low of $103.40 and a twelve month high of $169.51.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). The firm had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $2.85 EPS. On average, equities analysts anticipate that DaVita Inc. will post 9.71 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on DVA shares. UBS Group upped their target price on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Truist Financial boosted their target price on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Finally, Barclays upped their price objective on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $161.80.

Insider Activity

In other DaVita news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the sale, the chief executive officer now owns 837,835 shares of the company’s stock, valued at $138,284,666.75. The trade was a 5.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by company insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.